Goldman Sachs
NNVC icon

Goldman Sachs’s NanoViricides NNVC Stock Holding History

Goldman Sachs’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-73,566
Closed -$282K – 5632
2020
Q3 		$282K Sell
73,566
-15,022
-17% -$82.4K ﹤0.01% 4764
2020
Q2 		$663K Sell
88,588
-232,738
-72% -$1.62M ﹤0.01% 4221
2020
Q1 		$1.84M Buy
+321,326
New +$2.27M ﹤0.01% 3363
2018
Q4 		– Sell
-648
Closed -$5K – 5529
2018
Q3 		$5K Sell
648
-743
-53% -$5.73K ﹤0.01% 5507
2018
Q2 		$12K Buy
1,391
+746
+116% +$9.16K ﹤0.01% 5529
2018
Q1 		$11K Buy
645
+2
+0.3% +$37 ﹤0.01% 5738
2017
Q4 		$11K Sell
643
-1
-0.2% -$20 ﹤0.01% 6194
2017
Q3 		$15K Sell
644
-587
-48% -$15.8K ﹤0.01% 6471
2017
Q2 		$33K Sell
1,231
-62
-5% -$1.53K ﹤0.01% 6458
2017
Q1 		$29K Buy
1,293
+444
+52% +$10.4K ﹤0.01% 6427
2016
Q4 		$18K Sell
849
-278
-25% -$7.41K ﹤0.01% 6669
2016
Q3 		$38K Buy
1,127
+450
+66% +$14.9K ﹤0.01% 6562
2016
Q2 		$22K Sell
677
-4,124
-86% -$150K ﹤0.01% 6691
2016
Q1 		$210K Buy
4,801
+3,514
+273% +$136K ﹤0.01% 5572
2015
Q4 		$30K Sell
1,287
-3,943
-75% -$94.5K ﹤0.01% 6747
2015
Q3 		$124K Sell
5,230
-8
-0.2% -$212 ﹤0.01% 6346
2015
Q2 		$181K Buy
5,238
+4,631
+763% +$176K ﹤0.01% 6221
2015
Q1 		$27K Sell
607
-3,809
-86% -$203K ﹤0.01% 6858
2014
Q4 		$240K Sell
4,416
-2,131
-33% -$141K ﹤0.01% 6006
2014
Q3 		$393K Sell
6,547
-4,746
-42% -$373K ﹤0.01% 5495
2014
Q2 		$955K Buy
11,293
+1,068
+10% +$75.8K ﹤0.01% 4732
2014
Q1 		$654K Buy
10,225
+325
+3% +$27.8K ﹤0.01% 5041
2013
Q4 		$950K Buy
+9,900
New +$1.02M ﹤0.01% 4784

Other funds holding NNVC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Goldman Sachs's NNVC Position: Q4 2020 in Review

Goldman Sachs sold out of NanoViricides (NNVC) in Q4 2020, closing a stake of 73,566 shares — an estimated $282K sold.

Goldman Sachs first reported a position in NNVC in Q4 2013 and held it in 23 quarters. The position peaked at $1.84M in Q1 2020. 29 funds tracked by Wall St. Rank hold NNVC as of Q4 2020.

  • Goldman Sachs reported no remaining NanoViricides position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 73,566 NanoViricides shares in Q4 2020, an estimated $282K.
  • Goldman Sachs first reported a position in NanoViricides in Q4 2013 and held it in 23 quarters.
  • Goldman Sachs's NanoViricides position peaked at $1.84M in Q1 2020.
  • 29 funds tracked by Wall St. Rank held NanoViricides as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.